| Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review HGC Van Spall, A Toren, A Kiss, RA Fowler Jama 297 (11), 1233-1240, 2007 | 1220 | 2007 |
| Evidence-based clinical guidelines for immigrants and refugees K Pottie, C Greenaway, J Feightner, V Welch, H Swinkels, M Rashid, ... Canadian Medical Association Journal, cmaj. 090313, 2011 | 647 | 2011 |
| Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation EB Ing, NR Miller, A Nguyen, W Su, LLCD Bursztyn, M Poole, V Kansal, ... Clinical Ophthalmology (Auckland, NZ) 13, 421, 2019 | 54 | 2019 |
| Incidence of discordant temporal artery biopsy in the diagnosis of giant cell arteritis B Durling, A Toren, V Patel, S Gilberg, E Weis, D Jordan Canadian Journal of Ophthalmology 49 (2), 157-161, 2014 | 54 | 2014 |
| Multivariable prediction model for suspected giant cell arteritis: development and validation EB Ing, G Lahaie Luna, A Toren, R Ing, JJ Chen, N Arora, N Torun, ... Clinical Ophthalmology, 2031-2042, 2017 | 50 | 2017 |
| Clinical optic disc evaluation in glaucoma ASC Reis, A Toren, MT Nicolela European Ophthalmic Review 6 (2), 92-97, 2012 | 18 | 2012 |
| Clinical predictors of positive temporal artery biopsy A Toren, E Weis, V Patel, B Monteith, S Gilberg, D Jordan Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 51 (6 …, 2016 | 17 | 2016 |
| Development of a predictive model for temporal artery biopsies E Weis, A Toren, D Jordan, V Patel, S Gilberg Canadian Journal of Ophthalmology 52 (6), 599-605, 2017 | 14 | 2017 |
| Societal and economic impact of poor glaucoma medication adherence F Aptel, A Toren Ophthalmology 127 (5), 599-600, 2020 | 6 | 2020 |
| Multivariable prediction model for suspected giant cell arteritis: development and validation. Clin Ophthalmol. 2017; 11: 2031-42 E Ing, G Lahaie Luna, A Toren, R Ing, JJ Chen, N Arora | 4 | |
| COVID-19 and the rationale for primary selective laser trabeculoplasty and diode laser transscleral cyclophotocoagulation in Africa D Milad, D Mikhail, M Lenzhofer, J Agré, A Toren Journal of Glaucoma 31 (4), 215-217, 2022 | 2 | 2022 |
| Examining Bias in Published Surgical Glaucoma Clinical Trials R Michael, H Zhang, S McIntyre, L Cape, A Toren Journal of Glaucoma 33 (1), 8-14, 2024 | 1 | 2024 |
| The impact of COVID‐19 on the wait times and severity of surgical glaucoma cases evaluated at a tertiary eye center H Zhang, S McIntyre, A Abu‐Dieh, A Toren Acta Ophthalmologica 102, 2024 | | 2024 |
| PP031 iStent® For Open Angle Glaucoma: Standard Or Emerging Care? G Asselin, R Drolet, A Toren, M Coulombe, M Rhainds International Journal of Technology Assessment in Health Care 33 (S1), 84-85, 2017 | | 2017 |
| Modified settings for transcleral cyclophotocoagulation of the ciliary body in glaucoma treatment A Toren, M Carriere Investigative Ophthalmology & Visual Science 57 (12), 6475-6475, 2016 | | 2016 |
| Success Rates And Risk Factors For Failure Of Bleb Needling Post Trabeculectomy A Toren, S Kulkarni, L Shuba, M Nicolela Investigative Ophthalmology & Visual Science 53 (14), 5945-5945, 2012 | | 2012 |
| Systematic review of the exclusion criteria of randomized controlled trials published in major medical journals. HG Van Spall, A Toren, R Fowler JOURNAL OF GENERAL INTERNAL MEDICINE 20, 83-83, 2005 | | 2005 |
| Public Health and Preventative Medicine A Toren University of Toronto Medical Journal 81 (2), 156-157, 2004 | | 2004 |
| What tests and strategies to use for whom and when? A Toren, MT Nicolela | | |
